What the next 50 years of reproductive rights activism can learn from the last 50
By Felicia Kornbluh,
The Washington Post
| 01. 20. 2023
In June 1973, the Southern Poverty Law Center began publicizing a case it was pursuing in defense of two Black children from Alabama, Minnie Lee and Mary Alice Relf. The Relf sisters, 14 and 12 years old, had been sterilized on the recommendation of a nurse employed by the federal government. The girls’ mother, who reportedly could not read or write, signed consent forms for the sterilization of her two young daughters with an “X” and said later that she thought she was authorizing a form of reversible birth control, not a permanent removal of her daughters’ reproductive capacity. Relf v. Weinberger burst onto the scene just six months after Supreme Court Justice Harry A. Blackmun published his opinion for the majority in Roe v. Wade on Jan. 22, 1973, 50 years ago this week. This was a time of celebration for most feminists, and justly so: Their movement, working ardently at the grass roots and uniting across many lines of difference, had persuaded the nation’s highest court to recognize people’s need to make autonomous choices about whether to end...
Related Articles
By Matt Novak, Gizmodo | 07.23.2025
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, Kennedy recently told Tucker Carlson that AI...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...